Bellicum Announces Clinical Presentations at the 22nd Congress of the European Hematology Association
Overall-cohort abstract on BPX-501 selected for presentation at Presidential Symposium Oral and poster presentations highlight BPX-501 data in leukemias and hemoglobinopathies HOUSTON, May 18, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq …